Lymphoid Malignancies clinical trials

Explore recruiting lymphoid malignancies clinical trials.

Recruiting lymphoid malignancies studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Lymphoid Malignancies trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1 Study of JNJ-87801493 in Combination with CD3 T-Cell Engagers

Spain, Denmark, France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 1b/2 Study of JNJ-90014496 in Adult Participants with B-cell Non-Hodgkin Lymphoma

Spain, Netherlands, Germany, France, Denmark, Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

Phase 1 First-in-Human Study of JNJ-95566692 in Participants with NHLs

Belgium, France, Spain

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Long-term follow-up study of patients who have previously been exposed to UCART19 (allogeneic engineered T-cells expressing a lentiviral-based anti-CD19 chimeric antigen receptor)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 1b Study of JNJ-80948543 in Combination with Other CD3 TCEs for R/R B-cell NHL

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Lymphoid Malignancies trials by city

Lymphoid Malignancies clinical trials

Recruiting lymphoid malignancies studies right now

225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL

Study Of Capecitabine Combined With Camrelizumab For Non-pCR TNBC With TLS After Neoadjuvant Chemoterapy

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

Study Evaluating ISM8207 in Participants With Advanced Solid Tumors and Relapsed/Refractory B-Cell Lymphoma

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

Efficacy and Safety of TKI Combined With Chemotherapy and Sequential CAR-T Cells in ND Adult Patients With Ph+ ALL

CD5 Chimeric Antigen Receptor (CAR) T Cells in Subjects With Relapsed or Refractory T-cell Malignancies

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

Expressive Writing for the Management of Stress in Cancer Survivors

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL

Using Augmented Reality to Promote Physical Activity in Children With Cerebral Palsy